DiaGenic ASA Awarded Research Grant of NOK 7.8 Million for Further Development of DiaGenics Tests for Early Detection of Alzheimer’s Disease

OSLO, Norway--(BUSINESS WIRE)--Regulatory News:DiaGenic (OSE:DIAG) has been granted NOK 7.8 million of the Norwegian Research Council`s BIA funds. The funds will be employed in an industry-oriented research project to improve robustness and reduce costs of procedure in blood based diagnostics of Alzheimer’s disease. The clinical samples will be sourced from DiaGenic’s biobank as well as the HUNT Biosciences biobank.